Social Sciences

Glover, V., Clow, A. and Sandler, M. 1993. Effects of dopaminergic drugs on superoxide dismutase: implications for senescence. Journal of Neural Transmission (supplement). 40, pp. 37-45.

Acolet, D., Modi, N., Giannakoulopoulos, X., Bond, C., Weg, W., Clow, A. and Glover, V. 1993. Changes in plasma cortisol and catecholamine concentrations in response to massage in preterm infants. Archives of Disease in Childhood. 68 (1), pp. 29-31. https://doi.org/10.1136/adc.68.1_Spec_No.29

Medvedev, A.E., Goodwin, B.L., Clow, A., Halket, J., Glover, V. and Sandler, M. 1992. Inhibitory potency of some isatin analogues on human monoamine oxidase A and B. Biochemical Pharmacology. 44 (3), pp. 590-592. https://doi.org/10.1016/0006-2952(92)90454-Q

Clow, A., Hussain, T., Glover, V., Sandler, M., Walker, M. and Dexter, D. 1992. Pergolide can induce soluble Superoxide dismutase in rat striata. Journal of Neural Transmission. 90 (1), pp. 27-31. https://doi.org/10.1007/BF01250515

Bhattacharya, S.K., Clow, A., Przyborowska, A., Halket, J., Glover, V. and Sandler, M. 1991. Effect of aromatic amino acids, pentylenetetrazole and yohimbine on isatin and tribulin activity in rat brain. Neuroscience Letters. 132 (1), pp. 44-46. https://doi.org/10.1016/0304-3940(91)90429-W

Clow, A., Hussain, T., Glover, V., Sandler, M., Dexter, D. and Walker, M. 1991. (−)-Deprenyl can induce soluble superoxide dismutase in rat striata. Journal of Neural Transmission. 86 (1), pp. 77-80. https://doi.org/10.1007/BF01250378

Halket, J., Watkins, P.J., Przyborowska, A., Goodwin, B.L., Clow, A., Glover, V. and Sandler, M. 1991. Isatin (indole-2,3-dione) in urine and tissues: detection and determination by gas chromatography—mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications. 562 (1-2), pp. 279-287. https://doi.org/10.1016/0378-4347(91)80585-Z

Watkins, P.J., Clow, A., Halket, J., Przyborowska, A. and Sandler, M. 1990. Isatin, regional distribution in rat brain and tissues. Neurochemistry International. 17 (2), pp. 321-323. https://doi.org/10.1016/0197-0186(90)90154-L

Clow, A., Glover, V., Oxenkrug, G.F. and Sandler, M. 1989. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain. Neuroscience Letters. 107 (1-3), pp. 331-334. https://doi.org/10.1016/0304-3940(89)90841-0

Clow, A., Davidson, J., Glover, V., Halket, J., Milton, A.S., Sandler, M. and Watkins, P.J. 1989. Isatin and tribulin concentrations are increased in rabbit brain but not liver following pentylenetetrazole administration. Neuroscience Letters. 107 (1-3), pp. 327-330. https://doi.org/10.1016/0304-3940(89)90840-9

Blaug, R. 1989. Staff anxiety and its management in a day nursery. Journal of social work practice. 3 (4), pp. 1-14. https://doi.org/10.1080/02650538908413396

Sandler, M., Clow, A., Watkins, P.J. and Glover, V. 1988. Tribulin: an endocoid marker for anxiety in man. Stress Medicine. 4 (4), pp. 215-219. https://doi.org/10.1002/smi.2460040406

Glover, V., Halket, J., Watkins, P.J., Clow, A., Goodwin, B.L. and Sandler, M. 1988. Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. Journal of Neurochemistry. 51 (2), pp. 656-659. https://doi.org/10.1111/j.1471-4159.1988.tb01089.x

Burke, P.D.M., Beyer, J., Cooper, J., Holden, G, Nectoux, F. and Resnik, K Burke, P.D.M. (ed.) 1988. The nuclear weapons world: who, how and where. London Pinter Publishers.

Davidson, J., Glover, V., Clow, A., Kudler, H., Meador, K. and Sandler, M. 1988. Tribulin in post-traumatic stress disorder. Psychological Medicine. 18 (4), pp. 833-836. https://doi.org/10.1017/S0033291700009764

Clow, A., Glover, V., Weg, M.W., Walker, P.L., Sheehan, D.V., Carr, D.B. and Sandler, M. 1988. Urinary catecholamine metabolite and tribulin output during lactate infusion. British Journal of Psychiatry. 152, pp. 122-126. https://doi.org/10.1192/bjp.152.1.122

Clow, A., Glover, V., Sandler, M. and Tiller, J. 1988. Increased urinary tribulin output in generalised anxiety disorder. Psychopharmacology. 95 (3), pp. 378-380. https://doi.org/10.1007/BF00181951

Clow, A., Glover, V., Sandler, M., Elwes, R. and Reynolds, E.H. 1987. Tribulin output in neurological disorders. British Journal of Clinical Pharmacology. 24 (3), pp. 403-404.

Elsworth, J.D., Dewar, D., Glover, V., Goodwin, B.L., Clow, A. and Sandler, M. 1986. Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding. Journal of Neural Transmission. 67 (1-2), pp. 45-56. https://doi.org/10.1007/BF01243358

Blaug, R. 1986. John Rawls and the protection of liberty. Social Theory and Practice. 12 (2), pp. 241-258.

Clow, A., Glover, V. and Sandler, M. 1985. Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam binding. Journal of Neurochemistry. 45 (2), pp. 621-625. https://doi.org/10.1111/j.1471-4159.1985.tb04031.x

Murugaiah, K., Theodorou, A., Clow, A., Jenner, P. and Marsden, C.D. 1985. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats. Psychopharmacology. 86 (1-2), pp. 228-232. https://doi.org/10.1007/BF00431715

Clow, A., Glover, V., Armando, I. and Sandler, M. 1983. New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor? Life Sciences. 33 (8), pp. 735-741. https://doi.org/10.1016/0024-3205(83)90778-6

Clow, A., Stolerman, I.P., Murray, R.M. and Sandler, M. 1983. Ethanol preference in rats: increased consumption after intraventricular administration of tetrahydropapaveroline. Neuropharmacology. 22 (4), pp. 563-565. https://doi.org/10.1016/0028-3908(83)90181-8

Bhattacharya, S.K., Glover, V., Sandler, M., Clow, A., Topham, A., Bernadt, M. and Murray, R.M. 1982. Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol. Biological Psychiatry. 17 (7).

Murugaiah, K., Theodorou, A., Mann, S., Clow, A., Jenner, P. and Marsden, C.D. 1982. Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum. Nature. 296, pp. 570-572. https://doi.org/10.1038/296570a0

Theodorou, A., Gommeren, W., Clow, A., Leysen, J., Jenner, P. and Marsden, C.D. 1981. Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain. Life Sciences. 28 (14), pp. 1621-1627. https://doi.org/10.1016/0024-3205(81)90317-9

Kolbe, H., Clow, A., Jenner, P. and Marsden, C.D. 1981. Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors. Neurology. 31 (4(2)), pp. 434-439.

Dyer, R.G., Murugaiah, K., Theodorou, A., Clow, A., Jenner, P. and Marsden, C.D. 1981. During one year's neuroleptic treatment in rats, striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated. Life Sciences. 28 (2), pp. 167-174. https://doi.org/10.1016/0024-3205(81)90549-X

Jenner, P., Clow, A., Reavill, C., Theodorou, A. and Marsden, C.D. 1980. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms. Journal of Pharmacy and Pharmacology. 32 (1), pp. 39-44. https://doi.org/10.1111/j.2042-7158.1980.tb12842.x

Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1980. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration. Psychopharmacology. 69 (3), pp. 227-233. https://doi.org/10.1007/BF00433087

Clow, A., Theodorou, A., Jenner, P. and Marsden, C.D. 1980. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration. European Journal of Pharmacology. 63 (2-3), pp. 135-144. https://doi.org/10.1016/0014-2999(80)90437-9

Clow, A., Theodorou, A., Jenner, P. and Marsden, C.D. 1980. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. European Journal of Pharmacology. 63 (2-3), pp. 145-157. https://doi.org/10.1016/0014-2999(80)90438-0

Luscombe, G., Clow, A., Jenner, P. and Marsden, C.D. 1979. Antagonism by propanol of central dopamine receptor stimulation is not related to β-adrenergic blockade. Journal of Pharmacy and Pharmacology. 31 (1), pp. 355-356. https://doi.org/10.1111/j.2042-7158.1979.tb13522.x

Clow, A., Jenner, P. and Marsden, C.D. 1979. Changes in dopamine-mediated behaviour during one year's neuroleptic administration. European Journal of Pharmacology. 57 (4), pp. 365-375. https://doi.org/10.1016/0014-2999(79)90499-0

Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1979. Neuroleptic drugs and the dopamine hypothesis. Lancet. 313 (8122), p. 934. https://doi.org/10.1016/S0140-6736(79)91424-7

Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1979. Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months. Nature. 278, pp. 59-61. https://doi.org/10.1038/278059a0

Jenner, P., Elliott, P.N.C., Clow, A., Reavill, C. and Marsden, C.D. 1978. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs. Journal of Pharmacy and Pharmacology. 30 (1), pp. 46-48. https://doi.org/10.1111/j.2042-7158.1978.tb13151.x

Jenner, P., Clow, A., Reavill, C., Theodorou, A. and Marsden, C.D. 1978. A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs. Life Sciences. 23 (6), pp. 557-561. https://doi.org/10.1016/0024-3205(78)90032-2

Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1978. An experimental model of tardive dyskinesias. Life Sciences. 23 (5), pp. 421-423. https://doi.org/10.1016/0024-3205(78)90146-7